"Improving Diet, Exercise And Lifestyle (IDEAL) for Women" Study
Słowa kluczowe
Abstrakcyjny
Opis
Overweight to obese female subjects, who are habitually low dairy consumers and between the ages of 19-45 years will be recruited from the McMaster University student and staff population and from the surrounding Hamilton area. At study entry, all subjects will be asked to complete a standard screening questionnaire to document their medical history, current medication use, physical activity level, smoking habits, and alcohol consumption. Subjects will also complete a calcium food frequency questionnaire. Before randomization and study commencement, baseline measures will be done. These include: anthropometrics, fasting blood samples, fasting urine sample, resting energy expenditure measures (REE), muscle and adipose biopsies, cardiovascular measures (blood pressure, heart rate, blood vessel stiffness and arterial elasticity) body composition (dual-energy x-ray absorptiometry [DXA]), and a 7-day baseline food record analysis. Also, subjects' strength and fitness will be assessed (1 repetition maximum (RM) and submaximal Astrand Test evaluations). During the study, fasting blood samples will also be taken at weeks 4, 8, 12 and 16, DXA will also be done at weeks 8 and 16, validated Body Image questionnaires will be filled out again t weeks 8 and 16, and body weight will be recorded every week. All other measures will be repeated after 16 weeks (1RM, Astrand Test, biopsies, cardiovascular measures, REE). Magnetic Resonance Imaging (MRI) will be carried out on a smaller portion of subjects on a voluntary basis at weeks 0 and 16. Apon completion of the baseline testing, subjects will be randomly assigned to one of the three intervention groups.
Part of the intervention will be in the form of 2 daily chocolate drinks (a post-exercise drink plus one extra drink per day). Drink composition will differ depending on which group subjects are randomized to. Drinks will be made to look and taste similar. In terms of the daily diets, the DairyPro (middle/second) group will employ the same macronutrient distribution as the Control (first) group but half the protein will be derived from dairy sources, with subjects being asked to consume, on top of their supplemental chocolate drink, 2 yogurts (100 g each). In the control group, protein will be derived from sources other than dairy. In the HiDairyPro (third) group, dietary protein will be manipulated so as to comprise twice as much dietary energy versus the other two groups (i.e., 30% of energy intake versus 15%). Protein (half of their daily requirement) will be derived from dairy protein by asking subjects to consume, on top of their supplemental chocolate drink, 1 serving (250 ml) of 1% regular milk, 4 yogurts (100 g each) and 2 pieces of cheese (21 g each).
Overview of supplemental drink composition and diet composition by group:
1. Control (Con) - a group consuming twice daily drinks containing no dairy protein or calcium. Daily protein (15% total kcals) should be from non-dairy sources (i.e. meat, egg, fish, chicken, lentils, beans, wheat gluten).
2. Dairy Protein Group (DairyPro) - a group consuming twice daily drinks containing 1% chocolate milk and at least half of their daily protein (15% total kcals) intake from dairy sources.
3. High Dairy Protein Group (HiDairyPro) - a group consuming twice daily drinks containing 1% artificially sweetened chocolate milk along with a diet formulated to contain 30% (as opposed to only 15% in the Con and DairyPro groups) of their dietary energy from protein with at least half of that coming from dairy protein.
Subjects will meet with a study dietitian/nutritionist at the beginning and biweekly throughout the 16 weeks, and be provided with individual dietary counseling to reduce daily calories by 500 kcal/d. Subjects will be provided with template diet records, nutrition information sheets and macronutrient specific exchange lists to help with dietary compliance and to promote healthy food choices. The weight-reducing diets will have macronutrient and micronutrient profiles that are in accordance with the dietary regulations set forth by Canada's Food Guide and the dietary reference intakes (DRIs). The macronutrient profile of the 2 moderate protein groups (control and DairyPro) will be 15:30:55 (PRO:Fat:CHO), whereas the subjects in the High dairy protein group (HiDairyPro) will consume a profile of 30:30:40 (15% substitution of carbohydrate for protein). Subjects will consume all other food (aside from their designated drinks) in any manner they choose in accordance with the macronutrient profile of their respective randomization allocations. Adherence to the prescribed diet will be via collection of assigned biweekly food records, frequent contact with subjects, and regular dietary counseling sessions.
In addition, all subjects will be given a custom exercise prescription consisting of supervised resistance exercise and aerobic exercise. Intensity and duration of all exercise sessions will be monitored and energy expenditure quantified using portable, validated units that integrate accelerometry, heat flux and skin temperature. Exercise will take place in a supervised setting at McMaster University. Subjects will perform exercise 7d/wk and will exercise supervised 5d/wk (Mon - Fri). Resistance training sessions will take place 2x/week. During these sessions, subjects will engage in a circuit weightlifting routine using guided motion machines.
Daktyle
Ostatnia weryfikacja: | 06/30/2011 |
Pierwsze przesłane: | 06/30/2008 |
Szacowana liczba przesłanych rejestracji: | 07/02/2008 |
Wysłany pierwszy: | 07/03/2008 |
Ostatnia aktualizacja przesłana: | 07/18/2011 |
Ostatnia opublikowana aktualizacja: | 07/19/2011 |
Rzeczywista data rozpoczęcia badania: | 06/30/2008 |
Szacowana data zakończenia podstawowej działalności: | 04/30/2010 |
Szacowana data zakończenia badania: | 12/31/2010 |
Stan lub choroba
Interwencja / leczenie
Behavioral: Exercise - Aerobic and Resistance
Behavioral: Dietary - Caloric Restriction
Faza
Grupy ramion
Ramię | Interwencja / leczenie |
---|---|
Experimental: Control A group consuming twice daily (post-exercise and in morning/afternoon) drinks containing no dairy protein or calcium. Daily protein intake (15% total kcals) should be from non-dairy sources (i.e. meat, egg, fish, chicken, wheat gluten). | |
Experimental: Dairy Protein A group consuming twice daily drinks (post-exercise and morning) containing 1% chocolate milk (in 1.5 cup servings = 3 cups/d). Daily protein intake is set at 15% total kcals with ~8% coming from dairy sources. | |
Experimental: High Dairy Protein A group consuming twice daily drinks of 1% artificially sweetened chocolate milk (in 1.5 cup servings = 3 cups/d). Their diet contains 30% protein (as opposed to only 15% in the Con and DairyPro groups) with at least 50% of that coming from dairy sources. |
Kryteria kwalifikacji
Wiek kwalifikujący się do nauki | 19 Years Do 19 Years |
Płeć kwalifikująca się do nauki | Female |
Przyjmuje zdrowych wolontariuszy | tak |
Kryteria | Inclusion Criteria: - Healthy pre-menopausal females - Body Mass Index (BMI) between 27-40 kg/m2 - Low dairy consumption (~<500 mg/d Ca2+) - Sedentary lifestyle (i.e., exercise less than once/week) - Regular menstrual cycle Exclusion Criteria: - Allergy to dairy protein - Lactose intolerance - Vegan diet - Pregnant - Taking vitamin or mineral supplements - Have a gastrointestinal disease or condition - Recent orthopedic injury - Diagnosed with heart, kidney, liver or pancreatic disease - Smoker - Alcohol consumption of more than 2 drinks/day |
Wynik
Podstawowe miary wyników
1. Fat mass, lean mass, bone mass (BMD, BMC), total mass (measured via DXA scan) [Measured at weeks 0, 8 and 16]
Miary wyników wtórnych
1. Blood sample analyses (lipids) [Measured at weeks 0, 4, 8, 12 and 16]
2. Muscle and adipose tissue biopsies [Measured at weeks 0 and 16]
3. Food record macronutrient and micronutrient analyses (7-day at beginning and end, and 3-day throughout intervention) [Biweekly from weeks 0-16]
4. Resting Energy Expenditure (metabolic cart determination). [Measured at weeks 0 and 16]
5. Fitness and strength measures (modified Astrand Test and 1 RM test) [Measured at weeks 0 and 16]
6. Blood sample analyses (Vitamin D [25OHD], PTH, A1c, glucose, insulin) [Measured at weeks 0 and 16]
7. Magnetic Resonance Imaging (MRI) *strictly on a voluntary basis [Measured at weeks 0 and 16]
8. Spot Urine Collection [Measured at weeks 0 and 16]
9. Body Image (Assessed with a validated questionnaire) [Measured at weeks 0, 8 and 16]
10. Cardiovascular Measures (Assessment of blood pressure, heart rate, blood vessel stiffness and arterial elasticity) [Measured at weeks 0 and 16]